Disease Description
Blood pressure refers to the force of blood pushing against artery walls as it is distributed throughout the body. Hypertension is a medical condition in which the blood pressure is elevated above the normal range. It is also referred to as high blood pressure or as an abbreviation as HT, HTN or HPN.
Persistent hypertension causes damage to the blood vessels and is a risk factor for many life threatening events including strokes, heart attacks, heart failure, renal failure and arterial aneurysms. Even moderate elevation of arterial blood pressure leads to shortened life expectancy. During a hypertensive crisis, defined as extremely high blood pressure — a top number (systolic pressure) of 180 millimeters of mercury (mm Hg) or higher or a bottom number (diastolic pressure) of 120 mm Hg or higher, urgent treatment is required.
Prevalence
The World Health Organization estimated in 2008 that the overall prevalence of raised blood pressure in adults aged 25 and over was around 40%. Worldwide, raised blood pressure is estimated to cause 7.5 million deaths annually.
Current Treatment
When an individual has high blood pressure, there are various treatment options. Lifestyle changes are important; a healthy diet, regular exercise, reducing sodium, and quitting smoking are all great options. There are many different medications that may also be prescribed including:
-Angiotensin-converting enzyme (ACE) inhibitors
-Angiotensin II receptor blockers (ARBs)
-Diuretics
-Beta-blockers
-Calcium channel blockers
-Alpha-blockers
-Alpha-agonists
-Renin inhibitors
-Combination medications
Evidence for and Proposed Mechanism of Action of Cannabinoid Therapeutics It has been shown that endocannabinoids have hypotensive and cardiodepressor activity. In a study by Kunos G. et al. in 2004, investigating CB-1 receptors in hypertensive mice they found that targeting the endocannabinoid system offers novel therapeutic strategies in the treatment of hypertension. -Kunos G. et al. Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension. Circulation. 2004;110:1996-2002.
Category
Critical Ailments
Created
Thursday, 13 November 2014
Group Admin
June 1, 2025, Pre-Launch Success! Click the below Image link to setup your Account and begin your Crypto Journey with us. All Crypto Coin Buyers receive a Limited Time Pre-Launch offer! The Time is Now.
1-Million Strong Killing Cancers!
Click the Below Image to Review our Cancer Drug Comparables
*** Warning this document contains graphic images.
CSi-VIP Awards & NASDAQ Updates
Please Click the Below Image:



The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.
Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.
We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.
Click here to review the Report:
Case No. 2:17-CV-02271-KJM-JDP
Inspire, Dream, Change
YOUR DIGITAL ERA Personal & Business Access Learning HUB
Above ANNOUNCEMENT: December 31, 2025, Cannabis Science Inc., Shareholder Close-out.
Pease Click the above Calendar image to book your time to speak with Mr. Dabney about "Your Final CSi-VIP Shareholder Legacy".
Cannabis Science Financials & FINAL CBIS/CSi-VIP Share Numbers. Click the above Image link to view the latest Report.
November 5, 2025
Cannabis Science Shareholder FINAL Audit Confirmations
Click the above Image link to view the latest Report
September 23, 2025
Cannabis Science Shareholder Audit Confirmations Underway now!
Click the above Image link to view the latest Report.
July 7, 2025
Click the above Image link to view the latest cancer Killing promotional video. This is where you can join our 1-Million Strong youtube page to view more videos as we proceed forward.
June 1, 2025, Pre-Launch Success
Click the above Image link to setup your Account and begin your Crypto Journey with us. All Crypto Coin Buyers receive a Limited Time offer!
*** Warning this document contains exciting images.
The FINAL “CBIS GIFT Shares” Issuances!
DECEMBER 2024, Cheers! & HAPPY HOLIDAYS !!!
ALL GIFT Shares 1, 2, & 3 being ISSUED !!!
LAST Steps:
Please confirm Yours NOW !!!
1. CONFIRM Correct Total Share Amount(s)
2. CONFIRM Correct Name(s) on CERTIFICATE
3. CONFIRM Correct Mailing Address
ASU/CSi-EDP-ECO-System
At it's FINEST !!!
WHICH ONE ARE YOU ??
Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???
We can make this HAPPEN way FASTER Working as a TEAM !!!
WHAT Matters is how much you CARE about KILLING CANCERS ...
This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.

2025 Audit considerations NASDAQ.
Cannabis Science Inc.
Share Structure 2025
Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.
Common Stock:
Authorized:
5,000,000,000
Issued:
2,839,095,296
Fully Diluted:
4,510,547,648
Class A Common Stock
Authorized:
100,000,000
Issued:
0
Class B Common Stock
Authorized:
1,500,000,000
Issued:
0
Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000
Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.
You already know our Extensive LIST of GROUNDBREAKING Products.
1-Million STRONG TV Coverage, HARVARD Award Success.
TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE
*** APPLY for FREE in CONFIDENCE and Success.
Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.
EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!
Jan 4, 2026
Hello Raymond, Francis Cormier here. Happy New Year!
Ray, November 5, 2025, was your last update to icannabinoid.com. In that update, you stated:...Jan 4, 2026
Hello Raymond, Francis Cormier here. Happy New Year!
Ray, November 5, 2025, was your last update to icannabinoid.com. In that update, you stated: I'll be sending the next CSi-EDP 'Financials/Audit UPDATE Report' in the next few days. In it, we'll officially close everything out with our in-house Financials, so we can officially start the Audit.
I am NOT a CSI-VIP Status Holder, even though I own 1.2 million original CBIS shares, so I don't receive your CSI-VIP Shareholder Legacy Reports. Therefore, I have to ask some QUESTIONS here:
(1) Have you officially closed everything out with our in-house Financials, AS STATED, so we can officially start the Audit? If not, why not?
(2) Has the AUDIT officially started? If not, why not?
Additionally, the November 5, 2025, UPDATE also time-lined the 'Audit & Pending NASDAQ Listing' activity as follows:
(1) 3-6 Months to Complete Audit Capital Raise
(2) 3-6 Months to Complete Full Audit
(3) 3-6 Months to Complete NASDAQ Filings
(4) 3-6 Months to Address Comments & Changes
QUESTIONS:
(1) Are you still in the "Raise Capital to Pay for the Audit" Step, or has that been completed already?
(2) Which of the 4 steps noted above are you currently working on?
(3) What is your conservative estimate for it to take for CBIS to be relisted on the Exchange (1-2 yrs)?
Lastly, the November 5, 2025, UPDATE does NOT speak to any current activity of the Strategic Partner "Strainsforpains." They are supposedly spearheading "Our 1-Million Strong Killing Cancer campaign." I initially thought that they were going to produce some of the CBIS Products, but just what has their contribution been? I don't see any and haven't heard of any either. I bought 23,000 shares of EBYH @ $0.26 - it is now trading for $0.16. I expected a lot more from them.
Anyway, thank you, Raymond, in advance of your response. Happy New Year.
Francis G. Cormier III
Show more
@Raymond can you share with us the SEC Filings? That would be public information right?
-
1